UNSPSC 51273915: Benzocaine/chlorobutanol/ethanol/menthol/tannic acid

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE700. This VA Drug Class (DE700) classifies this compound as belonging to the group LOCAL ANESTHETICS, TOPICAL.

UNSPSC 51273915 Benzocaine/chlorobutanol/ethanol/menthol/tannic acid is a Commodity code that in current state and local procurement activity describes topical pharmaceutical and over-the-counter products, though the recent solicitations tagged under it show significant misalignment with the code's nominal scope. The three identified opportunities focus on naloxone distribution, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals through cooperative purchasing — none of which center on the specific active-ingredient combination the code names. State and local procurement appears to tag pharmaceutical procurement broadly under this code rather than by specific formulation, creating ambiguity about what actually moves through it. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and state-administered cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states including Oregon).

Recent activity spans Florida, Texas, and the upper Midwest through cooperative vehicles. Seminole County issued an IFB (IFB60459723LAS) due July 26, 2023, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building in Sanford, Florida. The Texas HHS Commission posted an RFI (HHS0017013) on April 3, 2026, seeking vendor capabilities for a direct-to-manufacturer prescription program to improve fulfillment efficiency outside traditional pharmacy benefit manager and wholesaler channels. The Minnesota Department of Administration issued an RFP (S1070000015802) due March 26, 2026, through MMCAP for generic multi-source pharmaceuticals and OTC products to be supplied through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) with July 1, 2026, contract start and two-year initial terms. The code shows limited recent activity genuinely aligned with its stated formulation, and pursuing it requires clarifying whether the actual buying need matches the active-ingredient specification or whether broader pharmaceutical procurement is the operative category.